Specialty pharmaceutical company Cumberland Pharmaceuticals (Nasdaq: CPIX) today announced the publication of new real-world outcomes research demonstrating the safety and healthcare resource ...
today announced the publication of new real-world outcomes research demonstrating the safety and healthcare resource advantages of its Caldolor (ibuprofen) injection over ketorolac in both adult ...
– Real World Study Compared Over 150,000 Adult & Pediatric Patients –– Caldolor Associated with Fewer Adverse Drug Reactions –– Caldolor also ...
today announced the publication of new real-world outcomes research demonstrating the safety and healthcare resource advantages of its Caldolor (ibuprofen) injection over ketorolac in both adult and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback